BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22857015)

  • 21. Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma.
    Filippi AR; Ciammella P; Piva C; Ragona R; Botto B; Gavarotti P; Merli F; Vitolo U; Iotti C; Ricardi U
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):370-5. PubMed ID: 24613810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical relevance of different dose calculation strategies for mediastinal IMRT in Hodgkin's disease.
    Koeck J; Abo-Madyan Y; Eich HT; Stieler F; Fleckenstein J; Kriz J; Mueller RP; Wenz F; Lohr F
    Strahlenther Onkol; 2012 Aug; 188(8):653-9. PubMed ID: 22740169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimizing late effects for patients with mediastinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both?
    Aznar MC; Maraldo MV; Schut DA; Lundemann M; Brodin NP; Vogelius IR; Berthelsen AK; Specht L; Petersen PM
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):169-74. PubMed ID: 25754634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease.
    Antoni D; Natarajan-Ame S; Meyer P; Niederst C; Bourahla K; Noel G
    Radiat Oncol; 2013 May; 8():112. PubMed ID: 23638873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma.
    Hoppe BS; Flampouri S; Su Z; Latif N; Dang NH; Lynch J; Joyce M; Sandler E; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):449-55. PubMed ID: 22386373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma.
    Maraldo MV; Brodin NP; Aznar MC; Vogelius IR; Munck af Rosenschöld P; Petersen PM; Specht L
    Ann Oncol; 2013 Aug; 24(8):2113-8. PubMed ID: 23619032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left-sided breast cancer radiotherapy with and without breath-hold: does IMRT reduce the cardiac dose even further?
    Mast ME; van Kempen-Harteveld L; Heijenbrok MW; Kalidien Y; Rozema H; Jansen WP; Petoukhova AL; Struikmans H
    Radiother Oncol; 2013 Aug; 108(2):248-53. PubMed ID: 24044804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
    Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement.
    Lu NN; Li YX; Wu RY; Zhang XM; Wang WH; Jin J; Song YW; Fang H; Ren H; Wang SL; Liu YP; Liu XF; Chen B; Dai JR; Yu ZH
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):210-6. PubMed ID: 22436783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphoma.
    Liu X; Huang E; Wang Y; He Y; Luo H; Zhong M; Qiu D; Li C; Yang H; He G; Zhou J; Jin F
    Radiat Oncol; 2017 Apr; 12(1):76. PubMed ID: 28449713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late radiation toxicity in Hodgkin lymphoma patients: proton therapy's potential.
    Toltz A; Shin N; Mitrou E; Laude C; Freeman CR; Seuntjens J; Parker W; Roberge D
    J Appl Clin Med Phys; 2015 Sep; 16(5):167–178. PubMed ID: 26699298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.
    Lievens Y; Nulens A; Gaber MA; Defraene G; De Wever W; Stroobants S; Van den Heuvel F;
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):306-13. PubMed ID: 20888706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetric evaluation of 3-D conformal and intensity-modulated radiotherapy for breast cancer after conservative surgery.
    Mansouri S; Naim A; Glaria L; Marsiglia H
    Asian Pac J Cancer Prev; 2014; 15(11):4727-32. PubMed ID: 24969911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements?
    Ares C; Khan S; Macartain AM; Heuberger J; Goitein G; Gruber G; Lutters G; Hug EB; Bodis S; Lomax AJ
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):685-97. PubMed ID: 19615828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosimetric advantage of intensity-modulated radiotherapy for whole ventricles in the treatment of localized intracranial germinoma.
    Sakanaka K; Mizowaki T; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e273-80. PubMed ID: 21640515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric comparison of left-sided whole breast irradiation with 3D-CRT, IP-IMRT and hybrid IMRT.
    Xie X; Ouyang S; Wang H; Yang W; Jin H; Hu B; Shen L
    Oncol Rep; 2014 May; 31(5):2195-205. PubMed ID: 24604635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients.
    Deng X; Han C; Chen S; Xie C; Yi J; Zhou Y; Zheng X; Deng Z; Jin X
    J Appl Clin Med Phys; 2017 Jan; 18(1):25-31. PubMed ID: 28291936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation therapy planning for early-stage Hodgkin lymphoma: experience of the International Lymphoma Radiation Oncology Group.
    Maraldo MV; Dabaja BS; Filippi AR; Illidge T; Tsang R; Ricardi U; Petersen PM; Schut DA; Garcia J; Headley J; Parent A; Guibord B; Ragona R; Specht L
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):144-52. PubMed ID: 25670544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect on esophagus after different radiotherapy techniques for early stage Hodgkin's lymphoma.
    Jørgensen AY; Maraldo MV; Brodin NP; Aznar MC; Vogelius IR; Rosenschöld PM; Petersen PM; Specht L
    Acta Oncol; 2013 Oct; 52(7):1559-65. PubMed ID: 24047340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-arc volumetric modulated therapy improves dose distribution compared to static gantry IMRT and 3D conformal radiotherapy for adjuvant therapy of gastric cancer.
    Zhang T; Liang ZW; Han J; Bi JP; Yang ZY; Ma H
    Radiat Oncol; 2015 May; 10():114. PubMed ID: 25986069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.